These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38742151)

  • 1. FBXO22 is a potential therapeutic target for recurrent chondrosarcoma.
    Xin B; Chen H; Zhu Z; Guan Q; Bai G; Yang C; Zou W; Gao X; Li L; Liu T
    J Bone Oncol; 2024 Jun; 46():100605. PubMed ID: 38742151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation.
    Shen Z; Dong T; Yong H; Deng C; Chen C; Chen X; Chen M; Chu S; Zheng J; Li Z; Bai J
    Cell Death Discov; 2024 Mar; 10(1):151. PubMed ID: 38519492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage.
    De S; Holvey-Bates EG; Mahen K; Willard B; Stark GR
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34795058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.
    Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H
    Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO22, ubiquitination degradation of PHLPP1, ameliorates rotenone induced neurotoxicity by activating AKT pathway.
    Zheng X; Yu S; Xue Y; Yan F
    Toxicol Lett; 2021 Oct; 350():1-9. PubMed ID: 34182063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of FBXO22 in carcinogenesis.
    Cheng J; Lin M; Chu M; Gong L; Bi Y; Zhao Y
    Cell Death Discov; 2020; 6():66. PubMed ID: 32793396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers
    Li M; Zhao X; Yong H; Shang B; Lou W; Wang Y; Bai J
    Front Pharmacol; 2021; 12():778698. PubMed ID: 34950036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA SNHG14 promotes osteosarcoma progression via miR-433-3p/FBXO22 axis.
    Hou XK; Mao JS
    Biochem Biophys Res Commun; 2020 Mar; 523(3):766-772. PubMed ID: 31948764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCF
    Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ_0006282 Contributes to the Progression of Gastric Cancer by Sponging miR-155 to Upregulate the Expression of FBXO22.
    He Y; Wang Y; Liu L; Liu S; Liang L; Chen Y; Zhu Z
    Onco Targets Ther; 2020; 13():1001-1010. PubMed ID: 32099403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXO22 inhibits proliferation and metastasis of cervical cancer cells by mediating ubiquitination-dependent degradation of GAK.
    Li S; Shi L; Wang Y; Zhang L; Chu S; Li M; Bai J; Zhu W
    Exp Cell Res; 2023 Sep; 430(1):113719. PubMed ID: 37442264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondrosarcoma-from Molecular Pathology to Novel Therapies.
    Zając AE; Kopeć S; Szostakowski B; Spałek MJ; Fiedorowicz M; Bylina E; Filipowicz P; Szumera-Ciećkiewicz A; Tysarowski A; Czarnecka AM; Rutkowski P
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2.
    Ma J; Wu Y; Cheng S; Yang W; Zhong L; Li Q; Fang L
    Dig Dis Sci; 2023 May; 68(5):1913-1922. PubMed ID: 36515852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
    Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
    J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype.
    Zając A; Król SK; Rutkowski P; Czarnecka AM
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
    Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J
    Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.
    Chen Y; Zhou Y; Feng X; Wu Z; Yang Y; Rao X; Zhou R; Meng R; Dong X; Xu S; Zhang S; Wu G; Jie X
    Cell Death Dis; 2024 Jan; 15(1):104. PubMed ID: 38296976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM8 promotes chondrosarcoma cell migration and invasion by activating the NF-κB/MMP-13 signaling axis.
    Liu Y; Li ZH; Zhang L; Lu SB
    Anticancer Drugs; 2019 Aug; 30(7):e0790. PubMed ID: 31305294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of FBXO22 for Targeted Degradation of NSD2.
    Nie DY; Tabor JR; Li J; Kutera M; St-Germain J; Hanley RP; Wolf E; Paulakonis E; Kenney TMG; Duan S; Shrestha S; Owens DDG; Pon A; Szewczyk M; Lamberto AJ; Menes M; Li F; Barsyte-Lovejoy D; Brown NG; Barsotti AM; Stamford AW; Collins JL; Wilson DJ; Raught B; Licht JD; James LI; Arrowsmith CH
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.